HUTCHMED
116 hedge funds and large institutions have $525M invested in HUTCHMED in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 32 increasing their positions, 46 reducing their positions, and 28 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.28% less ownership
Funds ownership: 5.9% → 5.62% (-0.28%)
11% less funds holding
Funds holding: 130 → 116 (-14)
30% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 46
40% less capital invested
Capital invested by funds: $872M → $525M (-$346M)
46% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 28
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $135K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$45.7M |
| 2 |
MGIM
M&G Investment Management
London,
United Kingdom
|
+$16.2M |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$7.32M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$6.56M |
| 5 |
Renaissance Technologies
New York
|
+$5.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Sands Capital Management
Arlington,
Virginia
|
-$79.3M |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$17.1M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$8.38M |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$8.28M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$7.32M |
HCM Hedge Fund Activity: Q2 2022 in Review
116 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in HUTCHMED (HCM) for Q2 2022, worth a combined $525M — down 40% from $872M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of HCM and 15 opened new positions — a net loss of 13 holders — while 46 trimmed existing stakes and 32 added.
The largest buyer was Goldman Sachs, adding an estimated $45.7M. The largest seller was Sands Capital Management, exiting entirely with an estimated $79.3M sold.
- 116 institutional investors held HUTCHMED (HCM) as of Q2 2022, down from 130 in Q1 2022.
- Funds reported $525M of HUTCHMED stock for Q2 2022, down 40% quarter-over-quarter.
- 15 funds opened new HUTCHMED positions in Q2 2022 and 28 closed out, a net change of -13 holders.
- The largest HUTCHMED buyer in Q2 2022 was Goldman Sachs, an estimated $45.7M added.
- The largest HUTCHMED seller in Q2 2022 was Sands Capital Management, an estimated $79.3M sold.
Based on aggregated 13F filings for Q2 2022.